Research dossier
Clinical research on Selenium
7 trials reviewed across 6 indications.
Strongest evidence
Selenoenzyme cofactor function
Mechanism
Selenium is incorporated into 25 known human selenoproteins as the unusual amino acid selenocysteine. Glutathione peroxidases use it to neutralize lipid hydroperoxides. Thioredoxin reductases regenerate antioxidant systems. Iodothyronine deiodinases convert thyroxine (T4) to active T3. None of these enzymes function without selenium.
The cofactor case is settled biochemistry — selenium is an essential trace element and its absence collapses several antioxidant and thyroid-hormone pathways. The unsettled question is whether moving from replete to supraphysiological levels does anything useful in already-fed adults. The trial evidence on that question is consistently null or negative.
Required for life. Required at the RDA, not at supplemental doses on top of an adequate diet.
Trials cited
Keshan disease — selenium repletion in deficient populations
positive · Observational
Keshan Disease Research Group, 1979, Chinese Medical Journal; reviewed in Levander 1987 and subsequent literature0Keshan disease is a fatal cardiomyopathy that struck children and pregnant women in rural Chinese counties with extremely low soil selenium. Population-level selenium repletion through fortification and supplementation programs essentially eliminated the disease. This is the strongest clinical case for selenium in human nutrition — and it is a deficiency-correction case, not a supraphysiological supplementation case.
Repletion in a frankly deficient population is not the same intervention as adding 200 µg to an already-replete Western diet. The Keshan story is regulatory-grade evidence for selenium as an essential trace element, not for supplementation in well-nourished adults.
Autoimmune thyroid (Hashimoto's)
Mechanism
Iodothyronine deiodinases that convert T4 to T3 are selenoproteins, and the thyroid gland holds the highest tissue selenium concentration in the body. Selenium-dependent glutathione peroxidases are thought to dampen oxidative damage in the inflamed Hashimoto's thyroid.
Trials in Hashimoto's patients show modest reductions in anti-TPO antibody titers with 200 µg/day selenium over months. Whether this antibody drop translates to better clinical thyroid function or slower disease progression is unclear — most trials are short, small, and do not show consistent improvements in TSH or free T4.
Reasonable to discuss with an endocrinologist if you have Hashimoto's and low-normal selenium status. Not a substitute for levothyroxine and not supported for routine use in non-autoimmune thyroid issues.
Selenium for autoimmune thyroiditis (pooled trial evidence)
mixed · Meta-analysis
Wichman et al., 2016, Thyroid; consistent with Rayman 2018 commentaryn=540Pooled trials in Hashimoto's patients show modest reductions in anti-TPO antibody titers with 200 µg/day selenium over 3-6 months. The effect on actual thyroid function (TSH, free T4) is small and inconsistent. Quality-of-life signals exist but trials are heterogeneous and small.
Antibody titers are a surrogate marker — they can drop without clinical thyroid function meaningfully changing. Most trial participants had relatively recent diagnoses and were already on levothyroxine. Long-term clinical outcomes (progression to hypothyroidism, cardiovascular events) have not been demonstrated.
Immune function
Mechanism
Selenium supports T-cell proliferation, neutrophil function, and antioxidant defense in immune cells. Selenium deficiency has been linked to more severe viral infections and possibly increased viral mutation rates in animal models.
In genuinely deficient populations or selenium-poor soil regions, repletion is associated with better immune markers and possibly fewer severe viral infections. In replete adults, supraphysiological supplementation has not produced clear clinical benefit. Critical-care trials of high-dose IV selenium in sepsis (REDOXS and others) have been mostly null.
Helpful in documented deficiency. Not an immune booster for already-fed adults.
Cancer prevention
Mechanism
Selenoproteins reduce oxidative DNA damage and modulate apoptosis pathways implicated in tumor initiation. The mechanistic case for cancer prevention was the basis of two decades of supplementation enthusiasm.
The original NPC trial (1996) suggested selenium reduced total cancer and prostate cancer as secondary endpoints. SELECT, designed specifically to test that hypothesis in 35,533 men, found no reduction in prostate cancer from selenium and an increase in prostate cancer from vitamin E. The supplementation case for cancer prevention does not survive the replication.
Selenium supplementation is not a cancer prevention strategy. The most rigorous trial ever run on this question said no.
SELECT — Selenium and Vitamin E Cancer Prevention Trial (primary)
Null · RCT
Lippman et al., 2009, JAMAn=35533The largest cancer-prevention trial ever run for selenium. 35,533 healthy men randomized across four arms: selenium alone, vitamin E alone, both together, or placebo. Selenium alone produced no reduction in prostate cancer incidence. The trial was halted early for futility on cancer prevention and concerning signals in the vitamin E arms.
The healthy, well-nourished US/Canadian population was already replete in selenium at baseline. The trial does not address selenium supplementation in genuinely deficient populations.
SELECT updated follow-up — selenium plus vitamin E and prostate cancer
negative · RCT
Klein et al., 2011, JAMAn=34887Extended follow-up after the trial was stopped showed alpha-tocopherol significantly increased prostate cancer incidence (17% relative increase vs placebo). Selenium alone remained null on prostate cancer. The combined arm showed an intermediate non-significant trend. The original cancer-prevention rationale collapsed and an active harm signal emerged for the vitamin E arm.
The selenium-alone arm was not protective and not clearly harmful for prostate cancer. The vitamin E harm signal was the headline finding. Together they ended the supplementation case for cancer prevention.
Nutritional Prevention of Cancer trial — original positive cancer signal
positive · RCT
Clark et al., 1996, JAMAn=1312The original supplementation enthusiasm came from this trial. Selenium-enriched yeast did not reduce skin cancer (the primary endpoint), but secondary analyses showed lower total cancer incidence and lower prostate, colorectal, and lung cancer rates. These secondary findings drove a decade of selenium-cancer research and were the explicit rationale for SELECT.
The cancer benefits were secondary endpoints in a trial designed for skin cancer. The participants lived in a selenium-poor soil region and had below-average baseline selenium status — a different population from SELECT. The headline cancer-prevention finding did not survive the larger replication.
Cardiovascular health
Mechanism
Severe selenium deficiency causes Keshan disease, a fatal congestive cardiomyopathy. Selenoproteins are involved in protecting cardiac tissue from oxidative damage.
The cardiovascular case for selenium is essentially the deficiency case. Repletion prevents Keshan disease in low-soil regions. There is no convincing trial evidence that supplementation reduces cardiovascular events in already-replete adults; observational data even suggests a U-shaped curve where high serum selenium associates with worse cardiometabolic risk.
Required to prevent deficiency cardiomyopathy. Not shown to reduce coronary events at supplemental doses on top of a normal diet.
Keshan disease — selenium repletion in deficient populations
positive · Observational
Keshan Disease Research Group, 1979, Chinese Medical Journal; reviewed in Levander 1987 and subsequent literature0Keshan disease is a fatal cardiomyopathy that struck children and pregnant women in rural Chinese counties with extremely low soil selenium. Population-level selenium repletion through fortification and supplementation programs essentially eliminated the disease. This is the strongest clinical case for selenium in human nutrition — and it is a deficiency-correction case, not a supraphysiological supplementation case.
Repletion in a frankly deficient population is not the same intervention as adding 200 µg to an already-replete Western diet. The Keshan story is regulatory-grade evidence for selenium as an essential trace element, not for supplementation in well-nourished adults.
Glucose regulation and diabetes risk
Mechanism
Selenoprotein P interacts with insulin signaling and gluconeogenic pathways in the liver. Mechanistic work suggests very high selenium status can drive insulin resistance through selenoprotein P overexpression.
This is the rare entry where the supplementation evidence points to harm, not benefit. The Stranges secondary analysis of the NPC trial found increased incident type 2 diabetes in the selenium arm, concentrated in participants with the highest baseline selenium. Several observational cohorts since have shown the same U-shaped relationship between serum selenium and diabetes risk.
If anything, the metabolic case argues against supplementation in already-replete adults. The signal is clearest in those starting from high baseline selenium.
Nutritional Prevention of Cancer trial — type 2 diabetes secondary analysis
negative · RCT
Stranges et al., 2007, Annals of Internal Medicinen=1202Secondary analysis of the original Clark cohort found that selenium supplementation increased the risk of incident type 2 diabetes vs placebo. The harm signal was concentrated in participants with the highest baseline plasma selenium (>121.6 ng/mL), where supplementation pushed them into clearly supraphysiological territory.
Diabetes was a secondary endpoint, not pre-specified at trial design. The signal is consistent with later observational data linking high serum selenium to insulin resistance, but causality remains debated.
5 forms of Selenium compared
L-Selenomethionine
Well absorbed (>90%); high tissue retention via incorporation into general body protein
Best forThe most common form in supplements and the form used in SELECTBecause selenomethionine substitutes for methionine in proteins, it accumulates with chronic intake and washes out slowly. This is why mega-dosing is the wrong move with selenium — the reservoir builds quietly.
Sodium selenite
Moderate (~50%); not incorporated into general body protein, so less accumulation
Best forInorganic form, less expensive, used in some clinical and Keshan-disease repletion protocolsCheap and turnover-friendly. Not the form most consumer brands use because it's less marketable than 'organic-bound' selenium.
Sodium selenate
Well absorbed but excreted faster than selenomethionine
Best forInorganic form used in some fortified products and water suppliesSimilar to selenite in pharmacokinetics. Rare in consumer supplements.
Selenium-enriched yeast
Generally well absorbed; predominantly selenomethionine but composition varies by manufacturer
Best forUsed in NPC and SELECT (SELECT later switched to L-selenomethionine for consistency)Composition is not standardized between brands. The same '200 µg yeast tablet' from two manufacturers can deliver different ratios of selenomethionine, selenocysteine, and inorganic selenium. Treat label dose as a rough estimate.
Se-methylselenocysteine
Well absorbed; metabolized through a different pathway than selenomethionine
Best forResearch form proposed for cancer prevention based on preclinical modelsThe theoretical cancer-prevention advantage has not been demonstrated in human trials. SELECT killed the broader supplementation-for-cancer story before this form got a fair clinical test.
Are you deficient? Symptoms, risk groups, lab tests
WHO estimates roughly 1 billion people globally are affected by inadequate selenium intake, concentrated in low-soil regions of China, parts of Europe (especially the Balkans, Scandinavia, and parts of the UK), New Zealand, and certain African regions. Frank deficiency is rare in the United States.
Common symptoms
- Fatigue and weakness
- Hair loss or hair changes (note: also a sign of toxicity)
- Weakened immune function
- Brain fog and difficulty concentrating
- Infertility, particularly in men (selenium is required for sperm motility)
- Hypothyroid symptoms in long-standing deficiency
- In severe deficiency: cardiomyopathy (Keshan disease)
- In severe deficiency combined with iodine lack: Kashin-Beck osteoarthropathy
Who is at risk
People living in low-soil-selenium regions
Soil selenium content varies 100-fold globally. Parts of China (notably Heilongjiang, Sichuan, and Tibet), New Zealand, Finland (before national fortification), the Balkans, and certain African regions have low-selenium soils that translate into low-selenium crops and low population intake.
People on long-term parenteral nutrition without selenium
TPN formulations historically lacked selenium; chronic TPN without trace-element supplementation has caused frank deficiency including cardiomyopathy. Modern TPN formulations include selenium, but compounding errors still occur.
Severe Crohn's disease, short bowel syndrome, and other malabsorption states
Loss of absorptive surface area and chronic diarrhea reduce selenium uptake and increase fecal losses.
People undergoing dialysis
Hemodialysis can deplete plasma selenium; combined with chronic illness and reduced dietary intake, dialysis patients run lower than the general population.
Strict vegan diets in low-soil regions
Animal foods (especially seafood, organ meats, and Brazil nut consumption) are major selenium sources. Vegans in low-soil regions without intentional supplementation can run low; vegans in higher-soil regions usually do not.
People with HIV in selenium-poor regions
HIV depletes selenium through chronic inflammation and viral replication; deficiency in this group has been associated with worse outcomes in older epidemiology.
Lab markers
Plasma or serum selenium
Reflects recent intake. A normal value does not rule out tissue deficiency, and a high value can reflect harmless dietary intake (e.g. one Brazil nut the day before) rather than chronic excess.
Better:Plasma glutathione peroxidase activity, Selenoprotein P, Whole blood selenium
- Adequate (Western reference)
- 70-150 ng/mL (0.89-1.91 µmol/L)
- Deficient
- <70 ng/mL
- Concerning for chronic excess
- >160 ng/mL sustained
Plasma glutathione peroxidase activity
Functional marker. Plateaus once selenium status is adequate (~90 ng/mL plasma selenium), making it a better deficiency screen than excess marker.
Side effects and drug interactions
Side effects
Selenosis (chronic toxicity)
Severe · Chronic intakes above 400 µg/day; clear clinical syndrome documented above ~800-1,000 µg/day
The signature toxicity syndrome at chronic intakes above ~400 µg/day. Hair becomes brittle and starts shedding. Nails develop white spots, longitudinal ridges, and break easily. Breath takes on a garlic-like odor from exhaled dimethyl selenide. Neurological symptoms include irritability, peripheral neuropathy, and in severe cases cognitive impairment. The Enshi, China endemic-selenosis literature is the canonical human toxicity dataset.
Worse with:selenomethionine, selenium yeast
Garlic breath and metallic taste
Common · Often noticeable above 200-400 µg/day in sensitive individuals
Exhaled dimethyl selenide produces a distinctive garlic odor on breath. Often the first noticeable sign of high selenium intake.
GI upset (nausea, abdominal pain, diarrhea)
Uncommon
Acute high doses can produce GI symptoms within hours. Often reported with single doses above 1,000 µg.
Skin rash
Uncommon
Chronic high intake can produce dermatitis and skin lesions, documented in the Enshi selenosis cases.
Increased type 2 diabetes risk (signal)
Uncommon · Signal strongest at 200 µg/day supplementation on top of replete baseline
Stranges 2007 found increased incident T2D in the selenium arm of the NPC trial, particularly in participants with the highest baseline selenium status. Several observational cohorts since have shown a U-shaped relationship between serum selenium and diabetes risk.
Increased prostate cancer risk in combination with vitamin E
Severe · 200 µg selenium plus 400 IU vitamin E daily
SELECT extended follow-up showed alpha-tocopherol increased prostate cancer incidence by 17%. Selenium alone was null on prostate cancer; the combined arm showed an intermediate trend.
Acute selenium poisoning (rare)
Severe · Acute single-dose exposures above several thousand µg
Documented from supplement-manufacturing errors. A 2008 incident in the US involved a liquid supplement mislabeled with 200x the intended selenium content; affected consumers experienced hair loss, fatigue, muscle and joint pain, GI symptoms, and skin lesions.
Drug interactions
Other
chemotherapy agents (theoretical)Selenium has antioxidant effects that could theoretically interfere with chemotherapy drugs that rely on oxidative damage to kill cancer cells (e.g. platinum-based agents, anthracyclines). Clinical evidence for this concern is mixed.
Discuss any antioxidant supplementation, including selenium, with the oncology team during active chemotherapy.
Additive effect
anticoagulants (warfarin)antiplatelet agents (aspirin, clopidogrel)Selenium has mild antiplatelet effects at high doses, which could theoretically add to bleeding risk on top of anticoagulants or antiplatelets. The signal is small at typical supplemental doses.
If on warfarin or dual antiplatelet therapy, mention selenium supplementation during INR monitoring.
Other
statins (theoretical)Both statins and selenium status influence the CoQ10 / antioxidant pathway, and there is theoretical concern about additive oxidative effects at high selenium doses. Clinical relevance is unclear.
Routine selenium supplementation is not contraindicated with statins, but mega-dosing has no rationale and the theoretical concern is one more reason to stay near the RDA.
Reduces nutrient status
corticosteroids (chronic, high-dose)Chronic corticosteroid use can lower plasma selenium status; this is more a 'monitor for deficiency' concern than an over-effect risk.
Patients on chronic high-dose steroids should ensure adequate dietary selenium intake.
Other critical caveats
- Selenosis at chronic intakes above 400 µg/day causes hair loss, brittle nails, garlic breath, and neurological symptoms. The signature toxicity is well-documented in the Enshi, China endemic-selenosis literature and in supplement-manufacturing accident cases. Stay at or below the RDA from supplementation if you also eat a normal mixed diet.
- Brazil nut selenium content varies wildly with soil — published values range from roughly 50 to 700 µg per nut. One nut can cover the RDA; three nuts from a different region can exceed the upper limit. Never recommend 'a few Brazil nuts daily' as a precise selenium strategy. If you eat them, treat them as occasional, not as a measured dose.
- The two most rigorous trials of selenium for cancer prevention — SELECT and the long-term NPC follow-up — failed to support supplementation. SELECT also showed vitamin E increased prostate cancer risk in the combined arm. The 1990s supplementation-for-cancer story is refuted; do not take selenium with cancer prevention as the goal.
Frequently asked
Should I take a selenium supplement?
For most people in developed countries eating a mixed diet: no. The US, Canada, Japan, and most of Latin America have selenium-replete soils; routine intake usually meets or exceeds the RDA without effort. Supplementation has not been shown to prevent cancer, cardiovascular disease, or cognitive decline in already-replete adults, and the SELECT and Stranges trials raise harm signals at supplemental doses. The case for taking selenium is reserved for documented deficiency, severe malabsorption, long-term TPN, or specific autoimmune-thyroid contexts under physician guidance.Are Brazil nuts a good source of selenium?
Yes, with a giant caveat. Brazil nuts are the most concentrated dietary source of selenium on the planet — but the content varies wildly with the soil where the trees grew. Published values range from about 50 µg to 700 µg per nut. One nut from a high-selenium region can hit the entire RDA; three from the same bag can put you over the upper limit if you eat them daily. Treat Brazil nuts as occasional, not as a measured supplement. If you want a stable dose, a labeled selenium supplement at the RDA is more predictable than the nut.What about selenium for thyroid problems, especially Hashimoto's?
This is the one human-trial context with a real, repeated signal. In Hashimoto's autoimmune thyroiditis, 200 µg/day of selenium for 3-6 months produces modest reductions in anti-TPO antibody titers. The honest read: the antibody drop is real, but whether it translates to better clinical thyroid function (TSH, free T4) or slower progression to hypothyroidism is unclear. If you have Hashimoto's, raise it with your endocrinologist — don't self-prescribe. For non-autoimmune thyroid issues, there is no good case for selenium supplementation.What about selenium for cancer prevention?
Don't. The original Clark 1996 trial in selenium-poor-soil regions of the eastern US suggested selenium reduced total cancer as a secondary endpoint. SELECT, the largest cancer-prevention trial ever run on this question (35,533 men), tested it directly and found no reduction in prostate cancer from selenium and an increase in prostate cancer from vitamin E. Long-term NPC follow-up by Stranges also showed an increase in type 2 diabetes risk. The 1990s selenium-for-cancer enthusiasm did not survive replication. Skip the supplement for this reason.How do I know if I'm selenium deficient?
In a developed country with a mixed diet, you almost certainly aren't. True deficiency is essentially confined to people with severe malabsorption, long-term TPN, or living in specific low-soil regions (parts of China, the Balkans, Finland before fortification, parts of New Zealand). If you're concerned, your physician can order a plasma selenium level — 70-150 ng/mL is the typical adequate range, with values below 70 ng/mL suggesting deficiency. Plasma glutathione peroxidase activity is a complementary functional marker. Don't supplement based on vague symptoms alone; selenium deficiency is rarer than the supplement industry would have you believe, and the symptom list overlaps with dozens of more common issues.
References
- 01NIH Office of Dietary Supplements — Selenium Health Professional Fact Sheet
- 02WHO — Trace Elements in Human Nutrition and Health (selenium chapter)
- 03StatPearls — Selenium Toxicity (NCBI Bookshelf)
Last reviewed2026-05-07